The use of flutamide in complex therapy of women with acne affected by hyperandrogenism
Journal Title: Український журнал дерматології, венерології, косметології - Year 2018, Vol 0, Issue 2
Abstract
Objective — to determine the efficacy, safety, tolerability of the complex therapy, which includes flutamid, in women with acne affected by hyperandrogenism. Materials and methods. During 2014—2017, there were 117 women under observation who had acne illness of varying degrees of severity. The age of the patients varied from 18 to 35, the average age was (28.2 ± 3.2) years. The duration of the disease was from 1 to 8 years, on average — (4.5 ± 0.5) years. The prevalence of acne in the age group of 18 to 25 years was 32 %; in the group of 25—30 years — 29 %; in the group of 30 — 35 years — 39 %. The hormonal status was studied on the third — fifth day of the menstrual cycle by the definition of luteinizing hormone, progesterone, total and free testosterone, antimullerian hormone before treatment and at 1, 3, 6 months of the therapy; the sonographic assessment of the pelvic organs was performed on the second — fourth day of the menstrual cycle before treatment and at the sixth month of therapy. For all women with acute acne and hyperandrogenism, complex therapy was conducted with the prescription of one of the systemic antibiotics of the azithromycin rank or retinoid and included flutamid in the dose of 125 mg 3 times per day for 6 months and the appointment of external treatment. Results and discussion. 82 (70 %) patients had second — third degree of severity (clinical course of moderate severity), 35 (30 %) patients — fourth degree of severity (severe clinical course). 92 (78.6 %) patients had hyperandrogenism on the background of polycystic ovarian syndrome, the remaining 25 (21.4 %) patients had a mixed type of hyperandrogenism. During the first two weeks of the complex therapy 104 (89 %) patients, showed significant improvement, revealed as regression of comedones and superficial papulapustular elements of skin rash, and the maximum effect was achieved only after 6 weeks of therapy. In 13 (11 %) patients, skin clearing from the rash was slower and the significant clinical improvement was achieved after three months of therapy. Complete clinical recovery, revealed as complete absence of any signs of inflammation on the skin, was observed in 117 patients who had undergone the full course of six months of treatment. Analysis of the average values of laboratory parameters after the treatment showed the decrease of the total and free testosterone levels by 4 and 3.5 times, respectively, of the luteinizing and antimullerian hormone — by 2.7 and 1.8 times, respectively, the increase of progesterone level — by 1.5 times. Longterm results of treatment allowed marking steady clinical remission for one year after treatment in 111 (95 %) women. Positive changes of sonographic evaluation (ultrasonic diagnosis) after the treatment were noted in 70 (60 %) women, which were revealed as decrease of the thickness of capsules and the decrease or disappearance of small hypoechoic inclusions along the ovarian stroma. Conclusions. The necessary condition for the increase of the effectiveness of treating patients with acne is the correction of all links of the pathogenesis of the disease. With a similar clinical symptomatology, a different tactics of management of patients, aimed at a particular pathogenetic cause, will be required. Since laboratory diagnostics makes it possible to understand the individual links of the pathological process, for female acne patients, primarily of reproductive age, an evaluation of the androgenic status is required – detection of biochemical hyperandrogenism and analysis of the degree of androgen level increase, – which makes it possible to implement the appropriate changes in the treatment, including acne disease. To interrupt hyperandrogenism link in women with acne, confirmed by biochemical and instrumental studies, it is advisable to administer flutamide 125 mg 3 times a day for a total of 6 months in a complex therapy with a possible dose adjustment.
Authors and Affiliations
D. S. Polishchuk, S. I. Polishchuk, V. S. Komarnytska
Keywords
Related Articles
- EP ID EP341231
- DOI 10.30978/UJDVK2018-2-73
- Views 94
- Downloads 0
Effect of pain intensity on psychological state of patients with epidermolysis bullosa
The term «congenital epidermolysis bullosa» (EB) unites a group of rather rare, genetically and clinically heterogeneous diseases characterized by the formation of a certain amount of blisters and erosions (from single t...
Retinoids-phobia — main aspects of the problem and facts of evidence-based medicine as tool for its solution
The review focuses on the problem of phobias in the use of systemic retinoids in the treatment of patients with acne and is intended to provide dermatologists with necessary information on effective solution of this prob...
The forgotten problem of hair diseases: alopecia in Chernivtsi
The article deals with the historical situation and many cases of alopecia anagena in Chernivtsi in 1988. The paper presents a modern view on classification of alopecia diffusa, gives the definition of different forms...
Onychodistrophy in skin diseases and complex therapy with the use of preparation Onychocid® Emtrix
Objective — to study the clinical features of onychodistrophy in dermatoses and improve the effectiveness of therapy with Onychocid® Emtrix. Materials and methods. Based on the analysis of literature data and our own cl...
How oral collagen intake can be useful in dermatology
Collagen is the main component of dermis. It represents as much as 75 % of dry skin weight. With aging, collagen content decreases in the skin, because of a reduced production by the fibroblasts and higher metabolism rat...